MedTrace Logo

Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU

NCT02413242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2031

Last updated 2019-05-08

No results posted yet for this study

Summary

Intensive Care Unit (ICU) acquired pneumonia, including ventilator-associated pneumonia, is a frequently occurring health-care associated infection, which causes considerable morbidity, mortality and health care costs. Important pathogens causing ICU pneumonia are Staphylococcus aureus and Pseudomonas aeruginosa. The epidemiology of ICU pneumonia and patient-related and contextual factors is not fully described, but is urgently needed to support the development of effective interventions.

Conditions

  • Pneumonia
  • Pneumonia, Ventilator-Associated
  • Nosocomial Pneumonia

Interventions

OTHER

Various observed exposure(s) of interest

A risk prediction model will be developed to assess which risk factors are associated with the development of ICU pneumonia during ICU stay

Sponsors & Collaborators

  • MedImmune LLC

    collaborator INDUSTRY

  • Universiteit Antwerpen

    collaborator OTHER

  • Jan Kluytmans

    lead OTHER

Principal Investigators

  • Jan A.J.W. Kluytmans, Prof. · UMC Utrecht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413242 on ClinicalTrials.gov